1 Min Read
Aug 3 (Reuters) - Inotek Pharmaceuticals Corp
* Inotek Pharmaceuticals Corporation reports second quarter 2017 financial results and operational highlights
* Qtrly loss per share $0.24 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.